Basal-like breast cancer is an aggressive and metastatic subtype but does not respond to the targeted hormonal therapy due to a lack of hormone receptors such as ER and PR, which demands urgent development of alternative therapeutic strategies. The gene discussed is ESR1; the disease is breast cancer.